<DOC>
	<DOC>NCT02680158</DOC>
	<brief_summary>The purpose of this study is to compare acute tear production produced by the Oculeve Intranasal Lacrimal Neurostimulator with two control devices in participants with aqueous tear deficiency.</brief_summary>
	<brief_title>1-Day Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator</brief_title>
	<detailed_description>This is a prospective, randomized, controlled, double-masked, multicenter clinical trial in which subjects with aqueous tear deficiency will receive three different device applications in a randomized sequence.</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<criteria>Subjects with aqueous tear deficiency Literate, able to speak English or Spanish, and able to complete questionnaires independently Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol Chronic or recurrent epistaxis, coagulation disorders or other conditions that, in the opinion of the investigator, may lead to clinically significant increased bleeding Nasal or sinus surgery including nasal cautery or significant trauma Cardiac demand pacemaker, implanted defibrillator or other implanted electronic device Diagnosis of epilepsy Corneal transplant in either or both eyes Participation in any clinical trial with a new active substance or a new device within 30 days of the Screening Visit A woman who is pregnant, planning a pregnancy, or nursing at the Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>